Sui WF, Duan YX, Li JY, Shao WB, Fu JH. Safety and efficacy of transcatheter arterial embolization in autosomal dominant polycystic kidney patients with gross hematuria: Six case reports. World J Clin Cases 2024; 12(11): 1954-1959 [PMID: 38660552 DOI: 10.12998/wjcc.v12.i11.1954]
Corresponding Author of This Article
Jian-Hua Fu, Doctor, Director, Department of Interventional Radiology, Zhenjiang First People’s Hospital, No. 8 Dianli Road, Zhenjiang 212000, Jiangsu Province, China. suiweifan@126.com
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Apr 16, 2024; 12(11): 1954-1959 Published online Apr 16, 2024. doi: 10.12998/wjcc.v12.i11.1954
Safety and efficacy of transcatheter arterial embolization in autosomal dominant polycystic kidney patients with gross hematuria: Six case reports
Wei-Fan Sui, Yun-Xin Duan, Jian-Yun Li, Wei-Bin Shao, Jian-Hua Fu
Wei-Fan Sui, Yun-Xin Duan, Jian-Yun Li, Jian-Hua Fu, Department of Interventional Radiology, Zhenjiang First People's Hospital, Zhenjiang 212000, Jiangsu Province, China
Wei-Bin Shao, Department of Nephrology, Zhenjiang First People’s Hospital, Zhenjiang 212000, Jiangsu Province, China
Author contributions: Fu JH and Shao WB designed the research study; Fu JH, Li JY, Sui WF and Duan YX performed the research; Sui WF analyzed the data and wrote the manuscript; All authors have read and approve the final manuscript.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jian-Hua Fu, Doctor, Director, Department of Interventional Radiology, Zhenjiang First People’s Hospital, No. 8 Dianli Road, Zhenjiang 212000, Jiangsu Province, China. suiweifan@126.com
Received: December 27, 2023 Peer-review started: December 27, 2023 First decision: January 16, 2024 Revised: January 30, 2024 Accepted: March 19, 2024 Article in press: March 19, 2024 Published online: April 16, 2024 Processing time: 105 Days and 21.1 Hours
Abstract
BACKGROUND
To retrospectively report the safety and efficacy of renal transcatheter arterial embolization for treating autosomal dominant polycystic kidney disease (ADPKD) patients with gross hematuria.
CASE SUMMARY
The purpose of this study is to retrospectively report the safety and efficacy of renal transcatheter arterial embolization for treating ADPKD patients with gross hematuria. Materials and methods: During the period from January 2018 to December 2019, renal transcatheter arterial embolization was carried out on 6 patients with polycystic kidneys and gross hematuria. Renal arteriography was performed first, and then we determined the location of the hemorrhage and performed embolization under digital subtraction angiography monitoring. Improvements in routine blood test results, routine urine test results, urine color and postoperative reactions were observed and analyzed. Results: Renal transcatheter arterial embolization was successfully conducted in 6 patients. The indices of 5 patients and the color of gross hematuria improved after surgery compared with before surgery. No severe complication reactions occurred.
CONCLUSION
For autosomal dominant polycystic kidney syndrome patients with gross hematuria, transcatheter arterial embolization was safe and effective.
Core Tip: In this manuscript, we report the retrospective analysis to evaluate efficiency and safety of transcatheter arterial embolization in autosomal dominant polycystic kidney patients with gross hematuria in the Chinese population and currently there is no relevant article published.
